Cardax, Inc.
Cardax, Inc. (CDXI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cdxi · pe ratio · data through Dec 31, 2020
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cardax, Inc. (CDXI) measures how much investors pay for each dollar of the company's trailing earnings. CDXI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$6.79.
Source: FMP · /ratios-ttm · /analyst-estimates · 2020-12-31
PE Ratio History
2012 – 2020 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cardax, Inc.You CDXI | $0M | N/A | — | -$6.79 |
 Eloxx Pharmaceuticals, Inc. ELOX | $47M | N/A | — | -$5.34 |
 Cannabiz Mobile, Inc. LGBI | $0M | N/A | — | -$0.00 |
 MedAvail Holdings, Inc. MDVLQ | $0M | N/A | — | -$36.20 |
 Micron Solutions, Inc. MICRD | $0M | N/A | — | -$0.41 |
 Modern Technology Corp. MODC | $0M | N/A | — | -$5.00 |
 MetaStat, Inc. MTST | $0M | N/A | — | -$0.59 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2020-12-31Latest FY2020 | — | $-6.79 | — | |
2019-12-31 FY2019 | — | $-7.49 | — | |
2018-12-31 FY2018 | — | $-6.32 | — | |
2017-12-31 FY2017 | — | $-3.97 | — | |
2016-12-31 FY2016 | — | $-4.68 | — | |
2015-12-31 FY2015 | — | $-12.73 | — | |
2014-12-31 FY2014 | — | $-56.44 | — | |
2013-03-31 FY2013 | — | $-0.28 | — | |
2012-03-31 FY2012 | — | $-0.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cardax, Inc. (CDXI) measures how much investors pay for each dollar of the company's trailing earnings. CDXI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$6.79.
Frequently asked questions
CDXI pe ratio · 6 questionsCDXI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$6.79. Data sourced from Financial Modeling Prep via CDXI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cardax, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09